China Universal Asset Management Company’s Myriad Genetics MYGN Stock Holding History

China Universal Asset Management Company’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-17,468	Closed	-$478K	–	514
2024 Q3	$478K	Buy	17,468 +6,834	+64%	+$185K	0.05%	226
2024 Q2	$260K	Sell	10,634 -6,606	-38%	-$145K	0.04%	206
2024 Q1	$368K	Buy	17,240 +6,987	+68%	+$150K	0.05%	211
2023 Q4	$196K	Buy	10,253 +8,152	+388%	+$141K	0.04%	207
2023 Q3	$33.7K	Buy	2,101 +1,032	+97%	+$19.6K	0.01%	257
2023 Q2	$24.8K	Sell	1,069 -29	-3%	-$633	0.01%	246
2023 Q1	$25.5K	Buy	1,098 +275	+33%	+$5.58K	0.01%	198
2022 Q4	$11.9K	Buy	823 +68	+9%	+$1.27K	﹤0.01%	212
2022 Q3	$14K	Buy	+755	New	+$17.3K	0.01%	180

Other funds holding MYGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

China Universal Asset Management Company's MYGN Position: Q4 2024 in Review

China Universal Asset Management Company sold out of Myriad Genetics (MYGN) in Q4 2024, closing a stake of 17,468 shares — an estimated $478K sold.

China Universal Asset Management Company first reported a position in MYGN in Q3 2022 and held it in 9 quarters. The position peaked at $478K in Q3 2024. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2024.

China Universal Asset Management Company reported no remaining Myriad Genetics position as of Q4 2024 after selling out during the quarter.
China Universal Asset Management Company sold 17,468 Myriad Genetics shares in Q4 2024, an estimated $478K.
China Universal Asset Management Company first reported a position in Myriad Genetics in Q3 2022 and held it in 9 quarters.
China Universal Asset Management Company's Myriad Genetics position peaked at $478K in Q3 2024.
221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2024.

Based on China Universal Asset Management Company's 13F filing for Q4 2024, filed 24 Jan 2025.